REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharma-Fuzes Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: PHARMA-FUZES Gyogyszeresz Szolgaltato Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Pharma-Fuzes Bt. is based in Hungary, with the head office in Fuzesgyarmat. It operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on June 17, 1996. The total number of employees is currently 8 (2024). In 2023, the company reported a net sales revenue increase of 10.58%. Its’ total assets recorded a negative growth of 4.61%. Pharma-Fuzes Bt.’s net profit margin increased by 0.76% in 2023.

Headquarters
Kossuth u. 12.
Fuzesgyarmat; Bekes; Postal Code: 5525

Contact Details: Purchase the Pharma-Fuzes Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Pharma-Fuzes Bt. report to view the information.
Outstanding Shares:
Purchase the Pharma-Fuzes Bt. report to view the information.
Registered Capital:
Purchase the Pharma-Fuzes Bt. report to view the information.
Financial Auditors:
Purchase the Pharma-Fuzes Bt. report to view the information.
Incorporation Date:
June 17, 1996
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pharma-Fuzes Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
10.58%
Total operating revenue
10.81%
Operating profit (EBIT)
13.39%
EBITDA
10.89%
Net Profit (Loss) for the Period
26.58%
Total assets
-4.61%
Total equity
1.96%
Operating Profit Margin (ROS)
0.17%
Net Profit Margin
0.76%
Return on Equity (ROE)
10.03%
Quick Ratio
0.04%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?